Autonomous

Autonomous Therapeutics is a biopharmaceutical company pioneering a novel class of medicines known as Autonomous Antivirals. The company's core technology utilizes Therapeutic Interfering Particles (TIPs), which are engineered, non-pathogenic versions of viruses that outcompete the actual virus for replication resources within a host. By "hitching a ride" on the virus's own machinery, these TIPs provide a broad-spectrum, resistance-proof approach to treating and preventing viral infections. The platform is designed to address high-burden respiratory viruses such as SARS-CoV-2 and Influenza, as well as chronic infections like HIV. Autonomous Therapeutics aims to create self-sustaining, single-dose treatments that can rapidly scale during pandemic outbreaks.